RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
🔬 Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. 📝 Nat Immunol. 👨🏻🔬 Crowther MD, et al. 🌎 https://t.co/bQjfuty3oL #science #research https://t.co/IH15PpDjMX
Paper: https://t.co/94TMI951i6
Accidental discovery of cancer cure? https://t.co/Auet1JLBAF
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/kHbWdycPQL
https://t.co/DpctrfaxGq MHC-like molecule MR1 is invariant in tumors - amazing to show that T-cells specifically recognize MR1-presenting tumor cells….exciting and applicable across #cancer types!
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
Una estrategia más para combatir el cáncer 🤓 https://t.co/lhWbPEY0ai
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 Sounds too good to be true, MR1 protein as a universal cancer target. Fascinating but I give it 10% chances going forward into the clinic. #immunotherapy https://t.c
RT @biolution_net: This is big: HLA-independent, pan-#cancer, pan-population #immunotherapy @cardiffuni @nature #research #medicine #tCell…
RT @JochenReiser: An engineered an omnipotent weapon against cancer - wow ! @AndrewZloza @RushUniversity @RushCancer
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
Intriguing and exciting research, but skeptical about their 'one size fits all' approach
research-article behind NATURE's paywall 😡 see - https://t.co/f6jtEYTvEb
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
@lexa_gene @StockDayPodcast Genome-wide CRISPR–Cas9 screening reveals ubiquitous #TCell cancer targeting via the monomorphic #MhcClass I-related protein MR1 https://t.co/ipUA0YM3Jx https://t.co/Jc5j3Kxj9Y
Cercana una cura contra el cáncer?: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology | https://t.co/YZawkhbrAx
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Lo_Zanzi: Not all #MAIT cells are equal! @NatImmunol a new unconventional #TCR that recognizes #tumor #selfligands (possibly #cancer…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @jeanfrancis72: new type of killer T-cell could lead to a universal cancer therapy. T-cells equipped with a new type of T-cell receptor…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @AdlenFoudi: Say hello 👋🏻 to promising universal cancer immunotherapy 💉 🧬 ♋️ Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell…
Really nice specificity for T cell killing of cancer cells expressing MR1. What is MR1 doing in cancer cells? Is this special TCR the anticancer key? @NatImmunol report: https://t.co/2ndYMF6f61 https://t.co/ge2OXtZRdQ
Insightful characterization of MR1 role in cancer with potential ramifications for tumor-agnostic immunotherapy development –https://t.co/cAsIzwL0ak
Huge development in the Cancer drug research https://t.co/Wu2002Uf0i
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
RT @Doctor_IMF: Not to be missed! Cardiff's own Professor of Immunotherapy @DrAnnAger being interviewed tonight at 18:30 on @BBCWalesNews a…
Not to be missed! Cardiff's own Professor of Immunotherapy @DrAnnAger being interviewed tonight at 18:30 on @BBCWalesNews about https://t.co/Se9clZgg2Q
not sure how other people in the field think about this but MR1 is clearly expressed on normal colorectal epithelium........
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Universal cancer immunotherapy? If it really makes it way into widely accessible therapeutic options, it'll be life-changing https://t.co/AT9XlKeSdl
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @curexcomplex: After having to do my own legwork since the BBC article didn't correctly link to the paper, here is the actual paper: htt…
RT @jeanfrancis72: new type of killer T-cell could lead to a universal cancer therapy. T-cells equipped with a new type of T-cell receptor…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/uDqNjwwjKm
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @CancerCrispr: Crispr-cas9 screening revealed a TCR that recognizes class I like molecule MR1 & can kill many tumor cells types independ…
Very exciting one : monomorphic MHC class I-related protein, MR1! https://t.co/ORN9san6CH
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: Acceso libre: https://t.co/iT8hjs9UHy
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
An amazing immunotherapy discovery by researchers at the University of Cardiff. The ubiquitous T cells and their potential to target cancer cells. Published in Nature Immunology: https://t.co/AaJ2tcwU1C
Exciting research published in @nature identifying a potential pan-cancer targeting T-cell. Early days still but this will surely lead to more promising work! https://t.co/QfE67fmoIZ
RT @JFLmir: The future of actual CAR-T cells?
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
Acceso libre: https://t.co/iT8hjs9UHy
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
RT @Andres_Lopez_C: 🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la may…
🧬 Se descubre un nuevo tipo de ‘killer T-cell’ equipado con un nuevo tipo de receptor capaz de reconocer y matar la mayoría de células cancerígenas e ignorar células sanas. Potencial tratamiento universal anti-cáncer. @NatImmunol #Immunotherapy 🧪 https:/
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
stayed up to have a good read on CRISPR-Cas9 .... https://t.co/OF8nHHKwOU
An engineered an omnipotent weapon against cancer - wow ! @AndrewZloza @RushUniversity @RushCancer
RT @AlefiyaN: Accidental discovery that may help cure cancer. The impact of this paper shared by the Telegraph and BBC https://t.co/UKIUnk…
So, I'm sure that most of you have heard/read been made aware of the new accidental finding of a MR1 t cell which can hopefully kill all cancers and leave healthy cells unharmed etc. Well the link and have a read for yourself. https://t.co/JHL3Y3yNY8
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @YaleMichaels: This T cell receptor appears to be able to target dozens of different cancer types while ignoring healthy tissues.. but w…
RT @IlanYLevine: @LibertyJen In fact, there were two potentially huge discoveries made this week: 1) Special T-cells which attack tumors…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
The work that was published: https://t.co/JzqRiXx3lK vs. what was reported in the BBC: https://t.co/r5h8chOgF1 Taking absolutely nothing away from the fantastic research that was done, it's scary how things can be blown out of proportion to such a degree!
RT @jeanfrancis72: new type of killer T-cell could lead to a universal cancer therapy. T-cells equipped with a new type of T-cell receptor…
new type of killer T-cell could lead to a universal cancer therapy. T-cells equipped with a new type of T-cell receptor recognises and kills most human cancer types while ignoring healthy cells. Nature Immunology https://t.co/Vuq5VcwVG9
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/3xX99Y85Xs
RT @zakkohane: Big deal POSSIBLE future cancer therapy: Beautiful result from CRISPR-Cas9 screen: MR1-targeted (MHC class I protein) T cell…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @IlanYLevine: Two potentially transformative tools against cancer found in one week! 1) Special T-cells which attack tumors but not hea…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/5n0ksLsLxX
Group in Cardiff identifies new class of receptor targeting T cell. Early days to judge full long-term therapeutic potential but interesting nonetheless. @NatImmunol https://t.co/V94D1NZf1W
RT @ARampotas: Universal CAR-Ts against a universal cancer antigen. This is huge ! Can t wait to see how it develops
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @ARampotas: Universal CAR-Ts against a universal cancer antigen. This is huge ! Can t wait to see how it develops